Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



John Johnston

John Johnston

Clinical Assessor, MHRA

John was a consultant in metabolic disorders in the UK’s National Health Service and transferred to the MHRA(UK) in 2007 where he now assesses advanced therapy medicinal products in the Biologicals Unit.

John has published on several aspects of metabolic disorders; more recently he has published on the challenges of personalised medicine being faced by current legislation.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd